Logo Lab Testing
covid 19 test kit main shdw

Zero Contact™ At-Home Saliva COVID-19 Test

FDA-EUA Authorized

Includes FedEx Overnight to the Lab and an official lab report. Can be used for travel in many circumstances.

$117
-
+

FDA Emergency Use Authorized
At-Home Saliva COVID-19 Test

Our self-collection testing kit for COVID-19 uses a hassle-free saliva sample to determine if your patients are infected with the SARS-CoV-2 virus. We’ve partnered with labs operating under the Emergency Use Authorization guidelines issued by the FDA. Our test kits include a complimentary priority return mailer for sending the sample to the lab. Within 48 hours of the lab receiving the sample, you will be able to access your result in your dashboard. If the result is positive, it is reported to appropriate authorities.

Collection Method:
Saliva Collection Tube

Digital Results Available Within:
48 hours of the lab receiving the sample

How It Works:

Step 1- Order Test Kits

Step 1: Order Test Kits

Use the form above to order kits, and your test kit will be delivered promptly

Step 2- Employees Register Test Kits

Step 2: Register Your Test Kit

When your test kit arrives, follow the simple instructions to ensure your test is registered with your personal information.

Step 3- Employees Collect Samples

Step 3: Collect Your Sample

Everything you need is included, and collection takes only a few minutes. Use the shipping return mailer to send your sample to the lab.

Step 4- Receive Your Results

Step 4: Receive Your Results

Once the lab receives your sample, you will get your test results and recommendations within 48 hours.

FDA Authorization

This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.